Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post ERCP Pancreatitis Prophylaxis, Effectiveness of Rectal Indomethacin vs Intravenous Ketorolac in the Pediatric Population

NCT05664074 is registered in ClinicalTrials.gov with David Vitale MD as lead sponsor.

NCT NCT05664074
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05664074 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post ERCP Pancreatitis Prophylaxis, Effectiveness of Rectal Indomethacin vs Intravenous Ketorolac in the Pediatric Population
Lead sponsor
David Vitale MD
Phase
Phase 4
Overall status
Completed
Start date
November 7, 2022
Completion date
February 5, 2025
Enrollment
192 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-ercp acute pancreatitis